Consistent with the functional augmentation of NMDAR, we found that the immunoreactivity of NMDAR2A and NMDAR2B was consistently increased in the cortical lesions of patients with FCD IIb and TSC and also FCD rats in this study. Here, GRIN2A is linked to tuberous sclerosis.